Treatment Optimization Pillar
Validation of Novel Targets
Project Key Words: Bacterial Pathogenesis; Phage Therapy
Principal Investigator: Amit Bhavsar, PhD
Co-Investigator(s): Tracy Raivio, PhD; Jon Dennis, PhD; Alexei Savchenko, PhD; Dongyan Niu, PhD
Project Theme: Innovation and Commercialization
The focus of this project is to examine alternatives to antibiotics as antimicrobial strategies. We will explore the use of phage or pathogenesis inhibitors in this context.
Why is This important?
We know that the rampant use of antibiotics is contributing to resistance against these drugs. We aim to develop non-antibiotic strategies to disarm AMR bacterial pathogens and prevent AMR transfer from the environment to people.
Leveraged Sources of Support
- Tricouncil - CIHR, NSERC
- International - NIH
- Institutional - UofC and Li Ka Shing Institute of Virology
Knowledge & Technology Exchange and Exploitation
Catalyze new research partnerships
Develop new antimicrobial targets that can be exploited by other researchers or industry
Highly Qualified Personnel
- 2 PhD, 4 MSc Students
- 1 Post-doctoral fellow
- 1 Research Associate
- 1 Research Technician